After watching the webinar, participants will be able to:
- Understand how to diagnose cardiac amyloidosis;
- Understand respective advantages and disadvantages of CMR and nuclear imaging; and
- Understand therapeutic implications of diagnosis of amyloidosis.
Cardiac amyloidosis is a public health problem with a poor outcome. There are currently medications available to treat this disease. Therefore, early detection of this condition is crucial.